DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,864 | +10.6% | 18,700 | +22.5% | 0.00% | – |
| Q2 2023 | $215,016 | -5.9% | 15,271 | +0.4% | 0.00% | – |
| Q1 2023 | $228,529 | +16.8% | 15,215 | +27.5% | 0.00% | – |
| Q4 2022 | $195,664 | -93.4% | 11,938 | -96.1% | 0.00% | -100.0% |
| Q4 2021 | $2,974,000 | -70.3% | 304,451 | +3.3% | 0.00% | -71.4% |
| Q3 2021 | $10,017,000 | -7.3% | 294,803 | -0.1% | 0.01% | 0.0% |
| Q2 2021 | $10,807,000 | -8.5% | 295,201 | +12.1% | 0.01% | -22.2% |
| Q1 2021 | $11,809,000 | -3.7% | 263,359 | +22.6% | 0.01% | -10.0% |
| Q4 2020 | $12,259,000 | +18.4% | 214,802 | +6.4% | 0.01% | +11.1% |
| Q3 2020 | $10,357,000 | +10.4% | 201,896 | +28.5% | 0.01% | 0.0% |
| Q2 2020 | $9,383,000 | +222.1% | 157,114 | +122.1% | 0.01% | +200.0% |
| Q1 2020 | $2,913,000 | – | 70,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |